GDF15 and Growth Control
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Growth/differentiation factor-15 (GDF-15) is a distant member of the transforming growth factor β (TGF-β) superfamily and is widely expressed in multiple mammalian tissues. Its expression is highly regulated and is often induced in response to conditions associated with cellular stress. GDF15 serum levels have a strong association with many diseases, including inflammation, cancer, cardiovascular diseases, and obesity, and potentially serve as reliable predictor of disease progression. A functional role for GDF15 has been suggested in cancer, cardiovascular disease, kidney disease and metabolic disease. However, the knowledge of its pathophysiological function at the molecular level is still limited and requires more investigation. Recent identification of the endogenous receptor for GDF15 may provide additional insight in to its' molecular mechanisms and relationship to disease states.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
Mullican, S. E., Lin-Schmidt, X., Chin, C.-N., Chavez, J. A., Furman, J. L., Armstrong, A. A., Beck, S. C., South, V. J., Dinh, T. Q., Cash-Mason, T. D., et al. (2017) · Nature Medicine · doi:10.1038/nm.4392 · Cited by 774
The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL
Emmerson, P. J., Wang, F., Du, Y., Liu, Q., Pickard, R. T., Gonciarz, M. D., Coskun, T., Hamang, M. J., Sindelar, D. K., Ballman, K. K., et al. (2017) · Nature Medicine · doi:10.1038/nm.4393 · Cited by 675 · cited 1×
“Another study examined GDF15 levels in 14577 patients with stable coronary heart disease and found GDF15 levels to be associated with cardiovascular death, sudden death, heart failure death, cancer death, and hospitalization for heart failure (Hagstrom et al., 2017).”
BackgroundSelf-citationGFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand
Yang, L., Chang, C.-C., Sun, Z., Madsen, D., Zhu, H., Padkjær, S. B., Wu, X., Huang, T., Hultman, K., Paulsen, S. J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4394 · Cited by 668 · cited 9×
“GDF15 mediated activation of RET phosphorylation induces signaling through ERK and AKT pathways (Hsu et al., 2017; Mullican et al., 2017; Yang et al., 2017).”
BackgroundMethodResultInfluentialSelf-citationKempf, T., Eden, M., Strelau, J., Naguib, M., Willenbockel, C., Tongers, J., Heineke, J., Kotlarz, D., Xu, J., Molkentin, J. D., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000202805.73038.48 · Cited by 651
Non-Homeostatic Body Weight Regulation Through a Brainstem-Restricted Receptor for GDF15
Hsu, J.-Y., Crawley, S., Chen, M., Ayupova, D. A., Lindhout, D. A., Higbee, J., Kutach, A., Joo, W., Gao, Z., Fu, D., et al. (2017) · Nature · doi:10.1038/nature24042 · Cited by 616
Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1
Johnen, H., Lin, S., Kuffner, T., Brown, D. A., Tsai, V. W.-W., Bauskin, A. R., Wu, L., Pankhurst, G., Jiang, L., Junankar, S., et al. (2007) · Nature Medicine · doi:10.1038/nm1677 · Cited by 612 · cited 6×
“The suggestion that GDF15 is an important regulator of body weight in humans (Johnen et al., 2007) unleashed a worldwide search for the receptor (s) underlying these effects.”
BackgroundInfluentialLarge-Scale Delineation of Secreted Protein Biomarkers Overexpressed in Cancer Tissue and Serum
Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530278100 · Cited by 503
Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study
Wang, T. J., Wollert, K. C., Larson, M. G., Coglianese, E., McCabe, E. L., Cheng, S., Ho, J. E., Fradley, M. G., Ghorbani, A., Xanthakis, V., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.129437 · Cited by 482 · cited 1×
“GDF15 was associated with all-cause mortality, incident heart failure, and major cardiovascular events (Wang et al., 2012).”
BackgroundAdela, R., & Banerjee, S. K. (2015) · Journal of Diabetes Research · doi:10.1155/2015/490842 · Cited by 474 · cited 1×
“Increased circulating GDF15 levels are also found in diabetes, cancer, cognitive impairment and cachexia patients (Johnen et al., 2007; Adela and Banerjee, 2015; Tsai et al., 2016; Wollert et al., 2017).”
BackgroundHsiao, E. C., Koniaris, L. G., Zimmers-Koniaris, T., Sebald, S. M., Huynh, T. V., & Lee, S.-J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.10.3742-3751.2000 · Cited by 302
NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism
Chrysovergis, K., Wang, X., Kosak, J., Lee, S.-H., Kim, J. S., Foley, J. F., Travlos, G., Singh, S., Baek, S. J., & Eling, T. E. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.27 · Cited by 241 · cited 1×
“In mice, over expression of GDF15 led to decreased food intake and increased energy expenditure (Macia et al., 2012; Chrysovergis et al., 2014) and this improved metabolic state led to decreased inflammatory cytokines and increased lifespan on both normal chow diet and a high fat diet (Wang X.”
BackgroundLong-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys
Xiong, Y., Walker, K., Min, X., Hale, C., Tran, T., Komorowski, R., Yang, J., Davda, J., Nuanmanee, N., Kemp, D., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan8732 · Cited by 236 · cited 1×
“These observations, initiated a considerable effort to develop therapeutics targeted to the GDF15 system including anti-GDF15 antibodies proposed as a novel therapeutic strategy to treat cancer – induced cachexia (Gyuris, Lerner, Lin, WO2016/049470), the effort to deorphanize the GDF15 receptor (discussed section “Con…”
BackgroundMacia, L., Tsai, V. W.-W., Nguyen, A. D., Johnen, H., Kuffner, T., Shi, Y.-C., Lin, S., Herzog, H., Brown, D. A., Breit, S. N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034868 · Cited by 211 · cited 1×
“In mice, over expression of GDF15 led to decreased food intake and increased energy expenditure (Macia et al., 2012; Chrysovergis et al., 2014) and this improved metabolic state led to decreased inflammatory cytokines and increased lifespan on both normal chow diet and a high fat diet (Wang X.”
BackgroundTGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulator
Tsai, V. W.-W., Macia, L., Johnen, H., Kuffner, T., Manadhar, R., Jørgensen, S. B., Lee-Ng, K. K. M., Zhang, H. P., Wu, L., Marquis, C. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055174 · Cited by 188 · cited 1×
“Conversely, GDF15 deficient mice were shown to have increased body weight, fat mass and food intake illustrating that endogenous GDF15 is a physiologically relevant regulator of metabolism (Tsai et al., 2013).”
BackgroundBaek, S. J., Okazaki, R., Lee, S.-H., Martinez, J., Kim, J.-S., Yamaguchi, K., Mishina, Y., Martin, D. W., Shoieb, A., Mcentee, M. F., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.015 · Cited by 175 · cited 1×
“After crossing with ApcMin mice, a mouse model for intestinal tumorigenesis, double heterozygotes had a significantly reduced polyp load (60%) compared with nontransgenic ApcMin littermates (Baek et al., 2006).”
BackgroundhNAG-1 increases lifespan by regulating energy metabolism and insulin/IGF-1/mTOR signaling
Wang, X., Chrysovergis, K., Kosak, J., Kissling, G., Streicker, M., Moser, G., Li, R., & Eling, T. E. (2014) · Aging · doi:10.18632/aging.100687 · Cited by 106
Cited by
Breen, D. M., Kim, H., Bennett, D., Calle, R. A., Collins, S., Esquejo, R. M., He, T., Joaquim, S., Joyce, A., Lambert, M., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.023 · Cited by 185
Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment
Polverino, F., Wu, T. D., Rojas-Quintero, J., Wang, X., Mayo, J., Tomchaney, M., Tram, J., Packard, S., Zhang, D., Cleveland, K. H., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202012-4510oc · Cited by 100
The Association of Aging Biomarkers, Interstitial Lung Abnormalities, and Mortality
Sanders, J. L., Putman, R. K., Dupuis, J., Xu, H., Murabito, J. M., Araki, T., Nishino, M., Benjamin, E. J., Levy, D., Ramachandran, V. S., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202007-2993oc · Cited by 84
Growth differentiation factor 15 (GDF15) in cancer cell metastasis: from the cells to the patients
Spanopoulou, A., & Gkretsi, V. (2020) · Clinical & Experimental Metastasis · doi:10.1007/s10585-020-10041-3 · Cited by 50
Lemmelä, S., Wigmore, E. M., Benner, C., Havulinna, A. S., Ong, R. M., Kempf, T., Wollert, K. C., Blankenberg, S., Zeller, T., Peters, J. E., et al. (2022) · eLife · doi:10.7554/elife.76272 · Cited by 28
“GDF15, a distant member of the transforming growth factor-β family (Bootcov et al., 1997; Emmerson et al., 2018), is upregulated in response to cellular stress and several diseases, including cancer.”
Background
Metadata
- Authors
- Emmerson, P. J., Duffin, K. L., Chintharlapalli, S., & Wu, X.
- Venue
- Frontiers in Physiology
- Publisher
- Frontiers Media SA
- Published
- 2018-11-27
- Volume
- 9
- Pages
- 1712-1712
- ISSN
- 1664-042X (ISSN-L)
- OpenAlex
- W2902150071
- Cited by
- 167
- References
- 16
- FWCI
- 13.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.